The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – Leerink upgraded Humana (HUM) to Outperform from Market Perform with a $513 price target. Looking at probable earnings power scenarios for 2028, the firm contends that the valuation compared to its current 2028 estimate of about $31 in EPS is “too attractive.” Piper Sandler also upgraded Humana to Overweight from Neutral with a price target of $463, up from $254. – Mizuho upgraded Bloom Energy (BE) to Outperform from Neutral with a price target of $242, down from $285. The company reported a strong quarter, with revenue and shipments beating expectations, the firm tells investors in a research note. – JPMorgan upgraded Sprouts Farmers Market (SFM) to Overweight from Neutral with a price target of $103, up from $80, following the Q2 report.
The company’s sales growth is at a “positive inflection point,” which could help drive a re-rating in the shares, the firm tells investors in a research note. – Wolfe Research upgraded uniQure (QURE) to Outperform from Peer Perform with a $65 price target. The stock has priced in less than 50% odds of success for approval amid concerns stemming from the recent advisory committees, but uniQure has “a stronger case than the market appreciates,” says the firm, which models 70% probability of success and $2B U.S. peak sales for AMT-130. – Keefe Bruyette upgraded Core Scientific (CORZ) to Outperform from Market Perform with a price target of $28, up from $25. The company delivered a near-term lease win, signing 529 megawatt of direct and indirect AMD (AMD) leases, the firm tells investors in a research note.